Evaluation of the Gametocytocidal Efficacy and Safety of Primaquine in Uncomplicated Falciparum Malaria in Uganda

PHASE3CompletedINTERVENTIONAL
Enrollment

468

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

March 31, 2013

Study Completion Date

May 31, 2013

Conditions
Falciparum Malaria
Interventions
DRUG

Primaquine

Single dose of oral primaquine phosphate. Comparator dose is 0.75mg/kg primaquine base. Each experimental arm is a different (reduced) dose of primaquine phosphate. Placebo contains no primaquine phosphate (non-active ingredients only).

Trial Locations (1)

Unknown

Walukuba Health Centre IV, Jinja

All Listed Sponsors
collaborator

Wellcome Trust

OTHER

lead

London School of Hygiene and Tropical Medicine

OTHER

NCT01365598 - Evaluation of the Gametocytocidal Efficacy and Safety of Primaquine in Uncomplicated Falciparum Malaria in Uganda | Biotech Hunter | Biotech Hunter